Evidence map›Paper›PMID 32227412›Full record

ArticleAngewandte Chemie (International ed. in English)2020

Two Distinct Structures of Membrane-Associated Homodimers of GTP- and GDP-Bound KRAS4B Revealed by Paramagnetic Relaxation Enhancement.

Ki-Young Lee, Zhenhao Fang, Masahiro Enomoto, Genevieve Gasmi-Seabrook, Le Zheng, Shohei Koide, Mitsuhiko Ikura, Christopher B Marshall

Open access · greenAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Article
  3. The Nanodisc System for Investigating Protein-Lipid Interactions.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Reconstitution and characterization of BRAF in complex with 14-3-3 and KRAS4B on nanodiscs.Protein science : a publication of the Protein Society · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ki-Young LeePrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, M5G 1L7, Canada.
Zhenhao FangPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, M5G 1L7, Canada.
Masahiro EnomotoPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, M5G 1L7, Canada.
Genevieve Gasmi-SeabrookPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, M5G 1L7, Canada.
Le ZhengPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, M5G 1L7, Canada.
Shohei KoideDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, and Perlmutter Cancer Center, New York University Langone Health, New York, NY, 10016, USA.
Mitsuhiko IkuraPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, M5G 1L7, Canada.ORCID 0000-0002-9524-1303
Christopher B MarshallPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, M5G 1L7, Canada.
University Health Network · CANYU Langone Health · US

Funding

Probing RAS-mediated Signaling with Monobody InhibitorsR01CA212608 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SHOHEI KOIDE, John P O'Bryan · 2017 to 2026
$5.8M
CIHR 410008598NCI NIH HHS R01 CA212608
6 · The paper itself

Abstract

KRAS homo-dimerization has been implicated in the activation of RAF kinases, however, the mechanism and structural basis remain elusive. We developed a system to study KRAS dimerization on nanodiscs using paramagnetic relaxation enhancement (PRE) NMR spectroscopy, and determined distinct structures of membrane-anchored KRAS dimers in the active GTP- and inactive GDP-loaded states. Both dimerize through an α4-α5 interface, but the relative orientation of the protomers and their contacts differ substantially. Dimerization of KRAS-GTP, stabilized by electrostatic interactions between R135 and E168, favors an orientation on the membrane that promotes accessibility of the effector-binding site. Remarkably, "cross"-dimerization between GTP- and GDP-bound KRAS molecules is unfavorable. These models provide a platform to elucidate the structural basis of RAF activation by RAS and to develop inhibitors that can disrupt the KRAS dimerization. The methodology is applicable to many other farnesylated small GTPases.

Indexed as

Binding SitesDimerizationGuanosine DiphosphateGuanosine TriphosphateHumansMagnetic Resonance SpectroscopyMolecular Dynamics SimulationProto-Oncogene Proteins p21(ras)Guanosine DiphosphateGuanosine TriphosphateKRAS protein, humanProto-Oncogene Proteins p21(ras)dimerizationKRASmembrane proteinsNMR spectroscopy

Identifiers

PMID32227412
PMCPMC7395670
OpenAlexW3013279701

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.